MedTrace Logo

Change in Exercise Capacity as Measured by Peak Oxygen Uptake After CTO PCI

NCT02499666 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2022-03-07

No results posted yet for this study

Summary

The purpose of this project is to objectively assess the change (improvement) in exercise capacity in patients undergoing routine percutaneous coronary intervention (PCI) for chronic total occlusion (CTO)

Conditions

Interventions

PROCEDURE

Percutaneous Coronary Intervention

As clinically indicated, patients will have a percutaneous balloon angioplasty and stent deployment of a chronic total occlusion (i.e., an artery that has a 100% blockage for several months).

DEVICE

Coronary stent

As clinically indicated, patients will have a coronary stent placement into their occluded coronary artery after successful balloon angioplasty

DRUG

Clopidogrel

As clinically indicated, patients who are not already on dual antiplatelet therapy will be started on a second agent such as clopidogrel.

Sponsors & Collaborators

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • Khaldoon Alaswad, MD · Henry Ford Health System

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-29
Primary Completion
2017-10-30
Completion
2017-10-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02499666 on ClinicalTrials.gov